Desvenlafaxine 70436-0013-04
- Manufacturer
- Slate Run Pharmaceuticals, Llc
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- August 1, 2020
- Listing Expires
- December 31, 2027
- Application
- ANDA210014
Need to source Desvenlafaxine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Desvenlafaxine Succinate | 100 mg/1 |
Drug Class
Cytochrome P450 2D6 Inhibitors [MoA]Norepinephrine Uptake Inhibitors [MoA]Serotonin Uptake Inhibitors [MoA]
Selected Package
70436-0013-04Selected30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70436-013-04)
Other packages for this product(1)
90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70436-013-06)